These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11136298)

  • 1. Effect of rifampicin on the pharmacokinetics and pharmacodynamics of glimepiride.
    Niemi M; Kivistö KT; Backman JT; Neuvonen PJ
    Br J Clin Pharmacol; 2000 Dec; 50(6):591-5. PubMed ID: 11136298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride.
    Niemi M; Backman JT; Neuvonen M; Laitila J; Neuvonen PJ; Kivistö KT
    Clin Pharmacol Ther; 2001 Apr; 69(4):194-200. PubMed ID: 11309547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rifampin on the pharmacokinetics and pharmacodynamics of gliclazide.
    Park JY; Kim KA; Park PW; Park CW; Shin JG
    Clin Pharmacol Ther; 2003 Oct; 74(4):334-40. PubMed ID: 14534520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide.
    Niemi M; Backman JT; Neuvonen M; Neuvonen PJ; Kivistö KT
    Clin Pharmacol Ther; 2001 Jun; 69(6):400-6. PubMed ID: 11406737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of rifampicin on the pharmacokinetics and pharmacodynamics of nateglinide in healthy subjects.
    Niemi M; Backman JT; Neuvonen M; Neuvonen PJ
    Br J Clin Pharmacol; 2003 Oct; 56(4):427-32. PubMed ID: 12968988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of glimepiride.
    Niemi M; Neuvonen PJ; Kivistö KT
    Clin Pharmacol Ther; 2001 Nov; 70(5):439-45. PubMed ID: 11719730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a concomitant single oral dose of rifampicin on the pharmacokinetics of pravastatin in a two-phase, randomized, single-blind, placebo-controlled, crossover study in healthy Chinese male subjects.
    Deng S; Chen XP; Cao D; Yin T; Dai ZY; Luo J; Tang L; Li YJ
    Clin Ther; 2009 Jun; 31(6):1256-63. PubMed ID: 19695392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypes.
    Niemi M; Cascorbi I; Timm R; Kroemer HK; Neuvonen PJ; Kivistö KT
    Clin Pharmacol Ther; 2002 Sep; 72(3):326-32. PubMed ID: 12235454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic modelling of the effects of glimepiride on insulin secretion and glucose lowering in healthy humans.
    Yun HY; Park HC; Kang W; Kwon KI
    J Clin Pharm Ther; 2006 Oct; 31(5):469-76. PubMed ID: 16958825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifampin decreases the plasma concentrations and effects of repaglinide.
    Niemi M; Backman JT; Neuvonen M; Neuvonen PJ; Kivistö KT
    Clin Pharmacol Ther; 2000 Nov; 68(5):495-500. PubMed ID: 11103752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations and effects of zopiclone are greatly reduced by rifampicin.
    Villikka K; Kivistö KT; Lamberg TS; Kantola T; Neuvonen PJ
    Br J Clin Pharmacol; 1997 May; 43(5):471-4. PubMed ID: 9159561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of rosuvastatin when coadministered with rifampicin in healthy males: a randomized, single-blind, placebo-controlled, crossover study.
    Zhang W; Deng S; Chen XP; Zhou G; Xie HT; He FY; Cao D; Li YJ; Zhou HH
    Clin Ther; 2008 Jul; 30(7):1283-9. PubMed ID: 18691987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glimepiride. A review of its use in the management of type 2 diabetes mellitus.
    Langtry HD; Balfour JA
    Drugs; 1998 Apr; 55(4):563-84. PubMed ID: 9561345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of rifampicin on the pharmacokinetics of pioglitazone.
    Jaakkola T; Backman JT; Neuvonen M; Laitila J; Neuvonen PJ
    Br J Clin Pharmacol; 2006 Jan; 61(1):70-8. PubMed ID: 16390353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrations and effects of buspirone are considerably reduced by rifampicin.
    Lamberg TS; Kivistö KT; Neuvonen PJ
    Br J Clin Pharmacol; 1998 Apr; 45(4):381-5. PubMed ID: 9578186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide.
    Bidstrup TB; Stilling N; Damkier P; Scharling B; Thomsen MS; Brøsen K
    Eur J Clin Pharmacol; 2004 Apr; 60(2):109-14. PubMed ID: 15034704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifampicin reduces plasma concentrations of celiprolol.
    Lilja JJ; Niemi M; Neuvonen PJ
    Eur J Clin Pharmacol; 2004 Jan; 59(11):819-24. PubMed ID: 14614579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
    Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of glimepiride in type 2 diabetic patients: compared effects of once- versus twice-daily dosing.
    Matsuki M; Matsuda M; Kohara K; Shimoda M; Kanda Y; Tawaramoto K; Shigetoh M; Kawasaki F; Kotani K; Kaku K
    Endocr J; 2007 Aug; 54(4):571-6. PubMed ID: 17603225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic modeling of glimepiride plasma concentration in healthy subjects.
    Antonesi IM; Potur R; Potur DM; Ghiciuc CM; Lupuşoru CE
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):949-53. PubMed ID: 22046814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.